Fabre-Kramer's Gepirone: Lots Of Studies, Not Enough Efficacy
This article was originally published in The Pink Sheet Daily
Executive Summary
Antidepressant's positive results in two trials were undermined by large number of negative and failed studies, FDA advisory committee concludes.